The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quantitative assessment of immune cell populations and associations with clinical outcomes in African-American (AA) versus Caucasian triple-negative breast cancer (TNBC).
 
Tess O'Meara
No Relationships to Disclose
 
Vesal Yaghoobi
No Relationships to Disclose
 
Kim Blenman
No Relationships to Disclose
 
Vasiliki Pelekanou
Employment - Sanofi
 
Andrea Silber
Honoraria - AstraZeneca; AstraZeneca
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
David L. Rimm
Stock and Other Ownership Interests - Pixel Gear
Honoraria - Amgen; Bristol-Myers Squibb; Ventana Medical Systems
Consulting or Advisory Role - Agendia; AstraZeneca; Bethyl Laboratories; Biocept; Bristol-Myers Squibb; Clearsight; Daiichi Sankyo; Five Prime Therapeutics; GlaxoSmithKline; Merck; Optra SCAN; Perkin Elmer; Ultivue
Research Funding - AstraZeneca/MedImmune (Inst); Cepheid (Inst); Lilly (Inst); NanoString Technologies (Inst); NextCure (Inst); Perkin Elmer (Inst); Pierre Fabre (Inst)
Patents, Royalties, Other Intellectual Property - Quantitative Immunofluorescence (AQUA) (Inst); Rarecyte Circulating tumor cells
Travel, Accommodations, Expenses - Genentech; NextCure; Ventana Medical Systems
 
Lajos Pusztai
Honoraria - Almac Diagnostics; AstraZeneca/MedImmune; Eisai; Genentech; Immunomedics; Merck; pfizer; Pieris Pharmaceuticals; Seattle Genetics/Astellas; Syndax
Consulting or Advisory Role - Athenex; H3 Biomedicine; Merck; Novartis; PierianDx; Seagen; Syndax
Speakers' Bureau - bioTheranostics
Research Funding - AstraZeneca; Genentech; Merck; Seagen